Delivery Order SPE2DB24D1104-SPE2DB25FXZJ7

Award Date 4/1/25
Potential Completion Date 4/2/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, with a ceiling value of $15,917.42 and a performance period through May 12, 2023. The contract is a firm fixed-price delivery order, which is a type of Indefinite Delivery Contract (IDC) that the...
This is a $6,815.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, with a period of performance through February 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,369.92 firm fixed-price contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has a period of performance through February 3, 2025 and was awarded on January 31, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has a ceiling value of $3,684.96 and runs through March 27, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $61,930.93 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of STELARA 90 MG/ML syringes to support medical supply requirements. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and...
This is a $3,343.24 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 45 MG/0.5 ML syringes. The contract has an ultimate completion date of March 6, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. The contract is a firm fixed-price delivery order with a ceiling value of $7,207.68 and an ultimate completion date of September 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has a firm fixed price ceiling value of $10,733.94 and a performance period ending on May 8, 2023. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) that...
This is a $3,684.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 4, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,116.20 contract is for the delivery of STELARA 45 MG/0.5 ML syringes, a specialty medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FXZJ7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has a firm fixed price of $6,390.54 and a period of performance through April 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/1/25, 8:23 AM